However, even with its relatively lower price compared to the US, the question remains — can she truly afford it? And if she ...

Eli Lilly's Mounjaro (Tirzepatide), a dual GIP and GLP-1 receptor agonist, has launched in India, generating buzz as a weight loss drug similar to Ozempic. Gastroenterologist Dr. Pal Manickam ...

The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors ...

Mounjaro is used to treat type 2 diabetes and obesity Credit: Getty Posting on TikTok, the mum-of-two, who is from the UK, shared a short clip showing off her new figure, leaving many totally stunned.

Ozempic (semaglutide) and Mounjaro (tirzepatide) are prescription drugs used to manage type 2 diabetes. They can also help with weight loss. Both drugs are injected once per week. Ozempic and ...

HYDERABAD (Reuters) -The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its availability, with some Indian doctors fielding ...